A Multi-Centre, Open Label, Non-Randomised, Non Interventional, 24 Weeks Study for the Efficacy and Safety of Rosuvastatin Following Its Administration in Real Life Clinical Practice in Greek Hypercholesterolaemic Patients.
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms RESEARCH
- Sponsors AstraZeneca
- 31 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2009 Actual patients number (810) added as reported by ClinicalTrials.gov.
- 04 Dec 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.